Reports Library Publication
Insight Consumer Healthcare Europe August / September 2025
30th September 2025 by CHC Insight
- Cough & Cold Mixed results despite stronger cold & flu season
- CCA Non-core Round-up Strong promotion for Ricola in Switzerland
- Allergy Remedies Switch activity underpins impressive growth
- A New View of Care Kenvue report looks at personal care routines’ impact on health
- Innovation Round-up Maxwellia to launch OTC version of Naprosyn
- News Review Europe responds to US paracetamol / autism claims
Order this report
Why buy this report?
"Despite higher levels of cold & flu reported across the region in 2024/25, there were mixed results among our seven core markets, with cost-conscious consumers turning to lower-cost generics. Poland was an exception however, recording a double-digit advance amid strong NPD from local players. Allergy remedies proved the winner among major categories as an early pollen season – in part prompted by unseasonably warm weather at start-2025 – resulted in a sales upswing for leading brands in several markets, while robust switch activity also provided a welcome boost."
Nicholas Hall